Abbott Laboratories (ABT)
106.24
+1.66
(+1.59%)
USD |
NYSE |
Oct 30, 16:00
106.18
-0.06
(-0.05%)
After-Hours: 20:00
Abbott Laboratories Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.488B |
| March 31, 2026 | 1.315B |
| December 31, 2025 | 3.315B |
| September 30, 2025 | 2.787B |
| June 30, 2025 | 2.047B |
| March 31, 2025 | 1.417B |
| December 31, 2024 | 2.868B |
| September 30, 2024 | 2.705B |
| June 30, 2024 | 1.96B |
| March 31, 2024 | 1.025B |
| December 31, 2023 | 3.038B |
| September 30, 2023 | 1.877B |
| June 30, 2023 | 1.203B |
| March 31, 2023 | 1.143B |
| December 31, 2022 | 2.326B |
| September 30, 2022 | 2.78B |
| June 30, 2022 | 2.41B |
| March 31, 2022 | 2.065B |
| December 31, 2021 | 3.067B |
| September 30, 2021 | 2.701B |
| June 30, 2021 | 2.128B |
| March 31, 2021 | 2.637B |
| December 31, 2020 | 3.798B |
| September 30, 2020 | 2.066B |
| June 30, 2020 | 1.322B |
| Date | Value |
|---|---|
| March 31, 2020 | 715.00M |
| December 31, 2019 | 2.416B |
| September 30, 2019 | 1.948B |
| June 30, 2019 | 1.06B |
| March 31, 2019 | 712.00M |
| December 31, 2018 | 1.765B |
| September 30, 2018 | 2.183B |
| June 30, 2018 | 1.244B |
| March 31, 2018 | 1.108B |
| December 31, 2017 | 1.64B |
| September 30, 2017 | 2.005B |
| June 30, 2017 | 1.351B |
| March 31, 2017 | 574.00M |
| December 31, 2016 | 1.17B |
| September 30, 2016 | 1.217B |
| June 30, 2016 | 909.00M |
| March 31, 2016 | -93.00M |
| December 31, 2015 | 828.00M |
| September 30, 2015 | 1.195B |
| June 30, 2015 | 941.00M |
| March 31, 2015 | 2.00M |
| December 31, 2014 | 1.238B |
| September 30, 2014 | 1.201B |
| June 30, 2014 | 900.00M |
| March 31, 2014 | 336.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 652.00M |
| Boston Scientific Corp. | -- |
| DexCom, Inc. | 269.20M |
| Globus Medical, Inc. | 209.74M |
| Intuitive Surgical, Inc. | 1.224B |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | 7.824B |
| Free Cash Flow Per Share (Quarterly) | 1.142 |
| Free Cash Flow to Equity (Quarterly) | 3.43B |
| Free Cash Flow to Firm (Quarterly) | 2.191B |
| Free Cash Flow Yield | 4.22% |